| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |